Raymond Prudo Chlebosz Akari Therapeutics PLC (AKTX) insider trading activity
Raymond Prudo Chlebosz is of Akari Therapeutics Plc. Currently has a direct ownership of 3.66 Billion shares of AKTX, which is worth approximately $4.76 Billion. The most recent transaction as insider was on May 31, 2024, when has been sold 0 shares (Ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.66B
0%
3M change
n/a
12M change
Total Value Held
$4.76 Billion
RP
Raymond Prudo Chlebosz
Boston, MA